TORONTO, ON / ACCESSWIRE / November 19, 2020 / Galway Metals Inc. (TSXV:GWM) (the "Company" or "Galway") is pleased to report assay results that were pending from drilling on the east and west sides of the Richard Zone at the Company's Clarence Stream project in southwest New Brunswick, Canada (Figure 1 and Figure 2). The latest results are highlighted by:

Hole 128 intersected 5.3 grams per tonne (g/t) Au over 25.5 metres (m), including 54.6 g/t Au over 0.5m, 20.9 g/t Au over 2.5m, and 16.4 g/t Au over 1.5m, (previously released as VG in 19m of quartz), starting at a vertical depth of 208m below surface. It is 92m below hole 125, but now interpreted to be a different vein. Hole 125 intersected 17.0 g/t Au over 5.5m, including 163.0 g/t Au over 0.5m with VG. The 5.3 g/t Au over 25.5m appears to line up best with the northern-most vein that Galway intersected at the time of the discovery of the Richard Zone, which returned 5.4 g/t Au over 11.0m (Figure 3). These are the first results from multiple new holes (pending assays) located in the 660m gap between the Richard Zone and the George Murphy Zone (GMZ), and is located 262m east of the previous eastern Richard limit defined by the discovery hole intersection that returned 7.3 g/t Au over 36.7m. This gap area between the GMZ and Richard Zones has now been reduced to 400m (Figure 4)
Hole 127 intersected 5.1 g/t Au over 10.2m including 91.4 g/t Au over 0.5m, (previously released as VG in 13m of quartz), starting at a vertical depth of 232m below surface. It is located on a step-out section 168m west of hole 118. Hole 118 intersected 9.7 g/t Au over 15.0m, including 267.0 g/t Au over 0.5m, which, at the time of its release on October 26, 2020, was 90m west of the previous western limit of the Richard Zone. The 5.1 g/t Au over 10.2m is located along the same section as previously-drilled hole 68, which returned 3.0 g/t Au over 12.0m, which was previously considered to be the eastern-most extent of the Jubilee Zone. Galway has now closed the previous 1km gap between the Richard and Jubilee Zones, but will undertake in-fill drilling in this area and toward Jubilee
The intersections in holes 127 and 68 on the west side, and 125 and 128 on the east side, extend mineralization along the Richard Zone to 926m, more than double the previous 400m (Figure 2 and Figure 4)
These results further confirm that the Jubilee, Richard and George Murphy Zones (GMZ) are part of the same mineralizing system that extends 2.5km. If the recently reported new discovery of 186.5 g/t Au over 0.6m were included, which is directly on-trend approximately 1km SW of Jubilee, the strike length of this mineralizing system extends to 3.5km (Figure 1)

Robert Hinchcliffe, President and CEO of Galway Metals, said, "The strong, wide mineralization in hole 128 in the gap between the Richard and George Murphy Zones plots by itself on the long section with lots of room to grow. This really beefs up the footprint of the gold system. With a strong balance sheet following Galway's $17 million June financing, the Company's recently expanded 5-rig, 75,000m drill program is fully-funded through the end of 2021. Galway's aim is to not only expand the existing zones, but to also continue making new discoveries to further demonstrate that Clarence Stream is an important new gold district in North America."

8 of the Highest-Grade Assays are from Galway's New Discoveries

The 3 highest grade individual assays from drilling on the entire Clarence Stream property are all from 3 of Galway's new discoveries, and now 8 of the top 12 assays are also from those 3 new discoveries. In addition to the 267.0 g/t Au over 0.5m and 163.0 g/t Au over 0.5m noted above, the Richard Zone also hosts 191.0 g/t Au over 0.5m (from 54.7 g/t Au over 2.5m), 373.0 g/t Au over 0.5m (from 6.2 g/t Au over 38.5m) and 495.0 g/t Au over 0.5m (from 10.6 g/t Au over 47.0m), while the nearby George Murphy Zone (GMZ) has returned 807.0 g/t Au over 1.25m (from 241.5 g/t Au over 4.2m), and 201.0 g/t Au over 0.5m (from 13.0 g/t Au over 8.7m), plus the recently-reported wildcat hole in the newest discovery intersected 186.5 g/t Au over 0.6m (June 24, 2020 press release).

The 660 Metre Gap Between the GMZ and Richard Zones is a Major Focus of Exploration

Holes 125 and 128 were drilled below mineralization in hole 86, which intersected 1.0 g/t Au over 6.3m and 5.8 g/t Au over 0.55m. These 3 holes were drilled in the 660m gap between the Richard Zone discovery hole intersection that returned 7.3 g/t Au over 36.7m and the western-most open good result at the GMZ that returned 12.2 g/t Au over 2.2m in hole 104. This 660m gap between the two zones is a major focus of exploration as Galway attempts to rapidly drill this gap area ahead of the resource update scheduled for the first quarter of 2021.

Table 1. Assay Results

Hole ID

From
(m)

To
(m)

Intercept
(m)

Intercept
(m) TW

(Unknown if not noted)

Au
g/t

Notes

RICHARD ZONE

GWM-20BL-128

57.00

61.00

pending

64.00

77.00

13.00

0.5

64.00

65.00

1.00

1.9

77.00

208.00

pending

208.000

233.50

25.50

5.3 VG

214.40

214.90

0.50

54.6

225.00

226.50

1.50

16.4

231.00

233.50

2.50

20.9

237.00

494.60

pending

GWM-20BL-127

62.10

96.50

pending

233.00

243.20

10.20

5.90

5.1

234.50

235.00

0.50

0.30

91.4 VG

246.00

415.15

pending

GWM-20BL-125

60.00

61.00

1.00

0.7

64.00

67.15

3.15

0.44

70.00

147.00

pending

150.00

155.50

5.50

17.0

incl.

154.00

154.50

0.50

10.8

incl.

154.50

155.00

0.50

163.0 VG

160.00

370.50

pending

GWM-20BL-118

67.00

187.70

pending

189.00

204.00

15.00

9.40

9.7

incl.

199.65

200.15

0.50

0.30

267.0 VG

208.00

335.80

pending

** previously reported; (TW=True Widths, which are calculated – sectional measuring may give slightly different numbers); True widths are unknown if not noted; VG=Visible Gold; 0.42 g/t Au was used for the bottom cut-off.

Table 2: Drill Hole Coordinates

Hole ID

Azimuth

Dip

Easting

Northing

Total Depth (m)

Zone

BL20-128

286

-78

653699

5021718

495

Richard-GMZ Trend

BL20-127

300

-85

653106

5021144

419

Jubilee-Richard Trend

BL20-125

140

-57

653619

5021817

370.5

Richard-GMZ Trend

BL20-118

320

-70

653195

5021234

368

Jubilee-Richard Trend

New Brunswick Junior Mining Assistance Program

Galway would like to acknowledge financial support from the New Brunswick Junior Mining Assistance Program, which partially funded drilling of the GMZ, Jubilee, and Richard Zones.

Geology and Mineralization

The recent discovery of the Richard Zone in hole 12 contains elevated levels of bismuth, arsenopyrite, and antimony, in multiple quartz veins, with tungsten in the vicinity. This is similar to other Clarence Stream deposits, which can be characterized as intrusion-related quartz-vein hosted gold deposits. Richard Zone contains multiple zones of quartz veining with sulfides and sericite alteration. In general, mineralization at Clarence Stream consists of 10-70% quartz stockworks and veins with 1-5% fine pyrite plus pyrrhotite plus arsenopyrite plus stibnite in sericite altered sediments. The Jubilee mineralization consists of 2%-5% disseminated pyrite, sphalerite, galena, arsenopyrite, chalcopyrite, and pyrrhotite in sediments with white to smoky grey quartz veining. Locally there is up to 10% sphalerite and semi-massive galena veinlets. The 2.5 km trend that hosts the GMZ, Richard and Jubilee Zones contains a mineralized mafic intrusive locally – similar to the South Zone, which currently hosts most of the property's last reported gold resources (September 2017). A more complete description of Clarence Stream's geology and mineralization can be found at www.galwaymetalsinc.com.

Review by Qualified Person, Quality Control and Reports

Michael Sutton, P.Geo., Director and VP of Exploration for Galway Metals, is the Qualified Person who supervised the preparation of the scientific and technical disclosure in this news release on behalf of Galway Metals Inc. All core, chip/boulder samples, and soil samples are assayed by Activation Laboratories, 41 Bittern Street, Ancaster, Ontario, Canada, who have ISO/IEC 17025 accreditation. All core is under watch from the drill site to the core processing facility. All samples are assayed for gold by Fire Assay, with gravimetric finish, and other elements assayed using ICP. The Company's QA/QC program includes the regular insertion of blanks and standards into the sample shipments, as well as instructions for duplication. Standards, blanks and duplicates are inserted at one per 20 samples. Approximately five percent (5%) of the pulps and rejects are sent for check assaying at a second lab with the results averaged and intersections updated when received. Core recovery in the mineralized zones has averaged 99%.

About the Company

Galway Metals is well capitalized with two gold projects in Canada, Clarence Stream, an emerging gold district in New Brunswick, and Estrades, the former producing, high-grade VMS mine in Quebec. The Company began trading on January 4, 2013, after the successful spinout to existing shareholders from Galway Resources following the completion of the US$340 million sale of that company. With substantially the same management team and Board of Directors, Galway Metals is keenly intent on creating similar value as it had with Galway Resources.

Figure 1: Clarence Stream Plan Map

Figure 2: Plan Map of the Richard Zone

Figure 3: Northern Vein Longitudinal Section

Figure 4: Longitudinal Section B

Should you have any questions and for further information, please contact (toll free):

Galway Metals Inc.
Robert Hinchcliffe
President & Chief Executive Officer
1-800-771-0680
www.galwaymetalsinc.com

CAUTIONARY STATEMENT: Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

This news release contains forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements made herein with respect to, among other things, the Company's objectives, goals or future plans, potential corporate and/or property acquisitions, exploration results, potential mineralization, exploration and mine development plans, timing of the commencement of operations, and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, exploration results being less favourable than anticipated, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, risks associated with the defence of legal proceedings and other risks involved in the mineral exploration and development industry, as well as those risks set out in the Company's public disclosure documents filed on SEDAR. Although the Company believes that management's assumptions used to develop the forward-looking information in this news release are reasonable, including that, among other things, the Company will be able to identify and execute on opportunities to acquire mineral properties, exploration results will be consistent with management's expectations, financing will be available to the Company on favourable terms when required, commodity prices and foreign exchange rates will remain relatively stable, and the Company will be successful in the outcome of legal proceedings, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information contained herein, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

SOURCE: Galway Metals Inc.

ReleaseID: 617463

JACKSON CENTER, PA / ACCESSWIRE / November 19, 2020 / Halberd Corp. (OTC PINK:HALB) reported the filing of a provisional patent application on a variation of Halberd's patented extracorporeal method to treat/eradicate Covid-19 from a patient's blood. By using an extracorporeal (outside the body) treatment method, the patient is exposed to far fewer potential negative side effects than with more conventional treatment regimens.

Halberd's provisional patent application, "Method For Treating And Curing Covid-19 Infection By Utilizing Radio Frequency Extracorporeally To Eradicate The Virus," discloses a unique application of extracorporeal exposure of virus-infected blood to a specifically created antibody which has been demonstrated to bind with the virus, but without deleterious side effects. This conjugate antibody/antigen pair is designed to react to an externally applied specific radio frequency which destroys the virus-antibody pair in real-time.

Dr. Mitchell S. Felder, inventor of this technology and consultant to Halberd Corporation's Scientific Advisory Board, stated, "A pathogen binding antibody binds to the target antigen and includes a moiety that reacts to a specific radio frequency. The result is the disease-causing pathogen is destroyed without further harm to the patient. This process could be similarly employed on any number of blood-borne diseases."

William A. Hartman, Chairman, President & CEO, added, "Of all the methods we have investigated, this seems to be the easiest and most effective in eliminating Covid-19 antigens. This would be intended to be administered in a hospital setting to those patients most adversely affected by Covid-19. The development of this technology will not interfere with, or otherwise delay, pursuit of our twin number one priorities — nasal spray preventative and fluorescent antibody rapid diagnostic test."

The details of the Halberd-ASU research contract can be viewed here.

If you would like to be added to our email subscriber list, click here and submit the form.

For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com;
support@halberdcorporation.com
www.halberdcorporation.com
Twitter:@HalberdC

About Halberd Corporation.
Halberd Corporation. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. Halberd's Articles of Incorporation prohibit the company from issuance of convertible debt which would result in dilution. See the company's Articles of Incorporation here.

The company holds the exclusive rights to the COVID-19 extracorporeal treatment technology provisional patent applications: "Method for Treating and Curing Covid-19 Infection;" "Method for Treating COVID-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in COVID-19 Patients;" "Method for Treating and Curing COVID-19 Infection by Utilizing a Laser to Eradicate the Virus," and, "Nasal Spray To Prevent The Transmission Of Covid-19 Between Humans," "Nasal Spray to Prevent the Transmission of Covid-19," and "Method For Treating And Curing Covid-19 Infection By Utilizing Radiofrequency Extracorporeally To Eradicate The Virus." Halberd also holds the exclusive rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287.

Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.

Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives –
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.

The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment or other strategies with regard to COVID-19.

The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.

We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be adverse to the pecuniary interests of the Company and of its shareholders.

SOURCE: Halberd Corporation

ReleaseID: 617470

Presentation Times and Weblinks Released for Over 60 Presenting Companies
Today: Thursday, November 19, 2020

NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for today's Virtual Microcap Investor Conference.

Virtual Agenda – All Times EST

Click on Company Name to Open Link to Zoom Meeting

8:30-9:00

Yatra Online Inc (YTRA)

Ardmore Shipping (ASC)

MTBC, Inc. (MTBC)

Tonix Pharma (TNXP)

Information Services Group (III)

****

9:15-9:45

****

Williams Industrial Services (WLMS)

Friedman LLP
Sponsor Presentation*

Helius Medical (HSDT)

Commercial Vehicle Group (CVGI)

C-COM Satellite (CMI)

10:00-10:30

Alico, Inc. (ALCO)

Ampco-Pittsburgh (AP)

****

Protech Home (PTQ)

Armstrong Flooring (AFI)

Bel Fuse (BELFB)

10:45-11:15

Jerash Holdings (JRSH)

Acme United (ACU)

Lincoln Education (LINC)

electroCore, Inc. (ECOR)

Basset Furniture (BSET)

Computer Task Group (CTG)

11:30-12:00

Envela Corp (ELA)

Coro Global (CGLO)

American Public Education (APEI)

Nephros, Inc. (NEPH)

VSE Corporation (VSEC)

AstroNova, Inc. (ALOT)

12:15-12:45

STRATTEC (STRT)

Blueknight Energy Partners (BKEP)

RCI Hospitality (RICK)

VolitionRx Ltd (VNRX)

OneSoft Solutions (OSS)

VerifyMe (VRME)

1:00-1:30

Lifetime Brands (LCUT)

LSB Industries, Inc. (LXU)

Assure Holdings (ARHH)

****

Charles River (CRAI)

Sonim Tech (SONM)

1:45-2:15

Thunderbird Entertainment (TBRD)

Good Natured Products (GDNP)

CorEnergy Trust (CORR)

Myomo (MYO)

Hill International (HILL)

WidePoint (WYY)

2:30-3:00

LiveXLive Media (LIVX)

U.S. Concrete (USCR)

InfuSystem (INFU)

Electromed (ELMD)

Limbach Facility Services (LMB)

POET Technologies (POET)

3:15-3:45

Tupperware (TUP)

Trecora Resources (TREC)

Civeo Corp. (CVEO)

Apollo Endosurgery (APEN)

DHI Group (DHX)

Verb Technology (VERB)

4:00-4:30

Boomer Holdings (BOMH)

Capstone Turbine (CPST)

ShiftPixy (PIXY)

****

Playboy Enterprises Inc.

GSI Technology (GSIT)

1x1s Only

****

****

Heritage Insurance (HRTG)

****

****

****

*Webinar regarding post-election tax implications. Video replay will be available.

About Sidoti

For over two decades, Sidoti has been a premier provider of independent securities research focused specifically on small- and micro-cap companies and the institutions that invest their securities, with most of our coverage in the $50 million – $3 billion market cap range. Our approach affords companies and institutional clients a combination of high quality research, a small- and micro-cap focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. We serve 500+ institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of AUM. Sidoti promotes meaningful interaction between issuers and investors in the small- and micro-cap space through our conferences www.sidoticonference.com and the hundreds of non-deal roadshows we host each year.

Contact

Sidoti Events Team
212-453-7031
conference@sidoti.com

SOURCE: Sidoti & Company, LLC

ReleaseID: 617496

VANCOUVER, BC / ACCESSWIRE / November 19, 2020 / Golden Lake Exploration Inc. (CSE:GLM) ("GLM" or the "Company")(OTCQB:GOLXF) is pleased to report further assay results from the summer drill program on the keystone Jewel Ridge gold property located near the town of Eureka, Nevada. A new, deeper elevation, mineralized zone was intersected in hole JR-20-09 at a depth of 160.0 meters, averaging 1.48 grams gold per tonne ("g/t Au") and 1.3 grams silver per tonne ("g/t Ag") over an interval of 10.67 meters. This represents a second mineralized horizon hosted in dolomite, in addition to the "Upper Mineralized Zone" that returned 1.25 g/t Au and 5.5 g/t Ag over 16.76 meters from surface in hole JR-20-09. These four holes wrap up the summer program results – assays are now pending from the most recent program announced October 20, 2020.

The Lower Mineralized Zone ("LMZ") intersection supports the geological model of a series of stacked, oxide, Carlin-type gold zones with a halo of mineralized material (above a projected 0.2-gram cut-off grade, 0.2 to 0.5 g/t Au range), in the Eureka Tunnel area, on the Jewel Ridge Property. Discovery of a stacked component of oxide gold mineralized horizons represents an attractive target for future drilling and significantly enhances the tonnage potential.

Eureka Tunnel Oxide Zone Drill Highlights

The Eureka Tunnel (aka South Eureka Tunnel) mine is located in the northwest quartile of the Jewel Ridge property, with the "Oxide Zone" (aka "Viking Zone") located east and north-east of the main portal. The Eureka Tunnel Oxide Zone comprises both Carlin-type and CRD -type ("Carbonate Replacement Deposits") oxide mineralization. A total of seven (7) Reverse-Circulation ("RC") drill holes were completed, comprising 1,048.57 meters, with assays for three vertical holes previously received (PR September 24, 2020), with a highlighted intercept of 2.80 g/t Au and 5.9 g/t Ag over 22.98 meters from surface. Highlights:

Upper Mineralized Zone ("UMZ") – the UMZ was consistently intersected in four holes, with intersections of higher-grade oxide gold mineralization over an average width of 21.34 meters, starting at surface, with a weighted average grade of 1.45 g/t Au and 4.8 g/t Ag. This target is open to the south, southwest, the northeast and north. All holes are vertical, and reported widths represent vertical intervals. Addition drilling is required to determine the true width of the mineralized zones.

Upper Zone Halo (UMZ and Low Grade) – Underlying the UMZ in four holes were wide intervals of lower grade oxide gold mineralization (0.2 to 0.5 g/t Au range). The Upper Zone Halo mineralization was intersected in the same four holes and had an average combined vertical width (4 holes) of 42.67 meters with a weighted average grade of 0.96 g/t Au and 3.2 g/t Ag. Including the lower grade halo material approximately doubles the mineralized intervals of the UMZ.

Lower Mineralized Zone ("LMZ") – A new, lower mineralized zone was intersected in hole RC-20-09 at depth of 160.02 meters, averaging 1.48 g/t Au and 1.3 g/t Ag over 10.67 meters, hosted in dolomite. Similar to the UMZ, lower grade mineralization (halo mineralization) underlies this interval, with a wider zone returning 0.83 g/t Au and 1.0 g/t Ag over 21.34 meters from a depth of 160.02 meters. Hole RC-20-09 was the only hole on the east flank of the valley that was drilled to depth (190.05 meters) to test this mineralized horizon (holes RC-20-06, 07, and 08 were too shallow). The multiple stacked nature of the oxide gold mineralized horizons significantly increases the enhances the tonnage potential of the Eureka Tunnel Zone.
Carbonate Replacement Deposit (CRD) Mineralization – CRD type mineralization has been historically mined from the Eureka Tunnel adit which extend approximately 600 meters to the west. Three discrete intersections (see table) of CRD mineralization were intersected in three holes from the recent program. CRD mineralization is associated with higher silver to gold ratios, higher arsenic (As) to gold ratio, and enhanced lead and zinc values.

All data from the recent drilling will be added to the 3D model to refine additional drill targets. The diamond drilling program at the Eureka Tunnel target has recently ended due to inclement weather conditions. A total of three short core holes were completed comprising 376.58 meters.

An IP ("Induced Polarization") geophysical survey is planned to be completed before the end of the month over the Eureka Tunnel area.

Mike England, chief executive officer of Golden Lake, states "We are very pleased with the results to date on the Jewel Ridge project and look forward to results yet to come from the current drill program. These results are giving us a good understanding of the geology and mineralization in place and will help guide us in future programs. Permitting is ongoing on the BLM parcels of land within Jewel Ridge that will be subject to future drill programs in 2021."

Drilling Quality Assurance and Quality Control

Procedures have been implemented to assure QA/QC of drill hole assaying being completed at ALS Labs in Elko, Nevada an ISO accredited assay laboratory. Samples are taken every 1.52 meters (5 foot intervals), with all intervals of drill holes being assayed. Samples are securely shipped and received by ALS Labs in Elko, Nevada, with chain-of-custody documentation through delivery. Mineralized commercial reference standards and coarse blank standards are inserted every 20th sample in sequence. All results will be analyzed for consistency. Assays for the last four holes are pending and will be reported when available.

About the Jewel Ridge Property

The Jewel Ridge property is located on the south end of Nevada's prolific Battle Mountain – Eureka trend, along strike and contiguous to Barrick Gold's Archimedes/Ruby Hill gold mine to the north and Timberline Resources' advanced-stage Lookout Mountain project to the south.

The property comprises 96 unpatented lode mining claims and 30 patented claims covering approximately 728 hectares (1,800 acres). The Jewel Ridge property contains several historic small gold mines. The Company's focus is on Carlin-style disseminated gold deposits, the primary focus in the area since the late 1970s.

Nevada Carlin-type gold deposits (CTGD) have a combined endowment of more than 250 million ounces, which are concentrated (85 per cent) in only four trends or camps of deposits: Carlin, Cortez (Battle Mountain-Eureka), Getchell and Jerritt Canyon. The Company cautions that results on adjacent and/or nearby projects are not necessarily indicative of results on the Company's property.

About Golden Lake Exploration Inc.

Golden Lake Exploration is a junior public mining exploration company engaged in the business of mineral exploration and the acquisition of mineral property assets. Its objective is to acquire, explore and develop economic precious and base metal properties of merit and to aggressively advance its exploration program on the Jewel Ridge property.

Qualified person

Golden Lake Exploration's disclosure of a technical or scientific nature in this news release has been reviewed and approved by Garry Clark, P.Geo., who serves as a qualified person under the definition of National Instrument 43-101.

ON BEHALF OF THE BOARD

"Mike England"
Mike England, CEO & DIRECTOR

FOR FURTHER INFORMATION PLEASE CONTACT: Telephone: 1-604-683-3995

TollFree:1-888-945-4770

Neither the Canadian Stock Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING STATEMENTS: This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward -looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at WWW.SEDAR.COM).

SOURCE: Golden Lake Exploration Inc.

ReleaseID: 617549

TORONTO, ON / ACCESSWIRE / November 19, 2020 / Anaconda Mining Inc. ("Anaconda" or the "Company") (TSX:ANX)(OTCQX:ANXGF) is pleased to announce drill results from an ongoing 15,000-metre infill drill program ("Drill Program") at its 100%-owned Goldboro Gold Project ("Goldboro" or the "Project") in Nova Scotia, Canada. The Drill Program is designed to convert priority Inferred Mineral Resources into Measured and Indicated Mineral Resources of the Goldboro Deposit as part of the ongoing feasibility study.

The current drill results are all from shallow drilling (<175 vertical metres) at the West Goldbrook Gold System ("WG Gold System") at the western end of the Goldboro deposit and demonstrate numerous mineralized intersections consistent with the current resource model (Exhibit A). These results demonstrate that at shallow levels of the WG Gold System there are numerous mineralized zones that confirm the geometry and location of the modelled mineral resource. A total of eleven (11) visible gold occurrences were also observed in these drill holes.

Selected composited highlights from the Drill Program include:

28.52 grams per tonne ("g/t") gold over 2.0 metres (125.6 to 127.6 metres) including 112.87 g/t gold over 0.5 metres in hole BR-20-146;
1.85 g/t gold over 15.0 metres (184.0 to 199.0 metres) including 29.13 g/t gold over 0.5 metres and 9.12 g/t gold over 0.5 metres in hole BR-20-147;
3.99 g/t gold over 4.5 metres (186.0 to 190.5 metres) including 26.80 g/t gold over 0.5 metres in hole BR-20-177;
8.68 gold over 1.9 metres (127.6 to 129.5 metres) including 17.60 g/t gold over 0.9 metres in hole BR-20-160;
4.29 g/t gold over 3.6 metres (27.0 to 30.6 metres) including 26.70 g/t gold over 0.5 metres in hole BR-20-158;
6.65 g/t gold over 2.0 metres (23.0 to 25.0 metres) including 17.40 g/t gold over 0.5 metres in hole BR-20-176; and
3.72 g/t gold over 3.5 metres (76.0 to 79.5 metres) including 12.70 g/t gold over 0.5 metres in hole BR-20-182.

A table of selected composite intersections from the Drill Program are shown in Table 1 below.

"As the current drill program progresses, we continue to increase our understanding of the Goldboro mineral resource and importantly its scale in areas of conceptual open pit resources. The shallow infill drilling in the western end of the Goldboro deposit is important as it confirms the geometry and location of the mineral resource and provides further insight into the extent to which we may be able to profitably mine within an open pit at Goldboro. The drill results from this program will allow us to refine the mineral resource model and upgrade resources to the Measured and Indicated categories at West Goldbrook and other areas of the deposit, which will be incorporated into the ongoing definitive feasibility study."

~ Kevin Bullock, President and CEO, Anaconda Mining Inc.

To date, a total of 12,780.5. metres in 79 drill holes (BR-20-105 to BR-20-183) have been completed under the Drill Program, with assays from drill holes BR-20-105 to BR-20-142 previously reported in news releases dated September 3, 2020; October 5, 2020; and November 11, 2020. Current results for 5,075.0 metres in thirty-six (36) diamond drill holes (BR-20-143 to BR-20-183, excluding BR-20-157, -163, -167, -169 and -171 which were taken for comminution analysis) include intersections of mineralized zones primarily within the WG Gold System. Diamond drill hole BR-20-133 was sampled out of sequence and will be reported in a later communication once assays have been received and evaluated.

The Drill Program is funded using existing flow through funds but has also benefited from a grant received from the Government of Nova Scotia through a Mineral Resources Development Fund, shared funding exploration grant MRDF-2020-SF-035.

The Company has critically considered logistical matters given the ongoing COVID-19 pandemic, to ensure that this Drill Program and any other programs are executed in a way that ensures the absolute health and safety of our personnel, contractors, and the communities where we operate.

Table 1. Selected Composite Highlights Within This News Release From The Drill Program.

Hole ID

From (m)

To (m)

Interval (m)

Gold (g/t)

Visible Gold (VG)

BR-20-143

128.1

128.9

0.8

6.85

and

164.7

165.7

1.0

1.04

BR-20-144

98.7

99.2

0.5

4.47

and

106.9

107.6

0.7

7.22

and

119.5

120.1

0.6

4.70

BR-20-145

79.0

79.5

0.5

11.19

BR-20-146

21.0

22.0

1.0

16.28

VG

and

115.2

118.5

3.3

0.92

and

125.6

127.6

2.0

28.52

VG

including

126.1

126.6

0.5

112.87

BR-20-147

106.5

108.0

1.5

1.42

VG

and

184.0

199.0

15.0

1.85

including

184.0

185.5

0.5

29.13

including

189.5

190.0

0.5

9.12

BR-20-148

156.5

161.5

4.5

0.63

and

172.3

174.3

2.0

2.02

BR-20-149

31.0

33.0

2.0

5.92

including

31.0

32.0

1.0

10.61

and

53.0

56.0

3.0

1.58

BR-20-150

18.5

19.0

0.5

2.78

and

31.5

33.5

2.0

0.59

BR-20-151*

113.0

117.9

4.9

0.92

and

126.3

126.9

0.6

12.40

VG

and

148.0

149.0

1.0

2.41

and

160.2

161.7

1.5

0.70

BR-20-152*

53.5

54.0

0.5

2.63

BR-20-154*

130.0

131.5

1.5

1.18

and

144.5

145.0

0.5

3.52

BR-20-155*

29.5

30.5

1.0

2.04

BR-20-156*

42.0

42.5

0.5

4.17

and

65.0

65.5

0.5

2.30

BR-20-158*

27.0

30.6

3.6

4.29

including

28.0

28.5

0.5

26.70

and

60.0

61.0

1.0

1.94

and

88.9

96.5

7.6

0.94

including

90.4

90.9

0.5

3.82

and

103.1

105.1

2.0

6.15

including

104.1

105.1

1.0

11.45

BR-20-159*

103.5

104.5

1.0

5.31

and

153.4

153.9

0.5

8.28

and

201.2

202.7

1.5

7.41

BR-20-160*

22.6

23.3

0.7

1.94

and

86.3

87.7

1.4

2.11

and

115.7

117.2

1.5

0.72

and

127.6

129.5

1.9

8.68

including

127.6

128.5

0.9

17.60

BR-20-161*

133.5

134.5

1.0

1.61

BR-20-164*

114.0

115.0

1.0

1.06

BR-20-168*

27.5

29.0

1.5

1.10

and

66.6

67.8

1.2

1.14

BR-20-172*

17.5

18.0

0.5

2.47

BR-20-173*

128.0

130.6

2.6

1.51

VG

and

158.4

159.0

0.6

3.53

and

165.7

166.5

0.8

1.32

BR-20-174*

44.0

46.6

2.6

1.28

including

45.6

46.6

1.0

2.61

and

97.2

99.5

2.3

1.30

VG

and

111.3

112.3

1.0

1.51

BR-20-175*

17.0

18.0

1.0

2.41

and

30.8

32.3

1.5

0.67

VG

and

35.8

36.8

1.0

1.16

and

61.8

63.8

2.0

1.56

and

72.9

73.4

0.5

2.22

and

138.6

139.6

1.0

1.42

and

162.5

164.5

2.0

1.27

including

164.0

164.5

0.5

3.53

BR-20-176*

23.0

25.0

2.0

6.65

including

24.0

24.5

0.5

17.40

and

33.5

34.0

0.5

4.02

and

38.0

39.0

1.0

1.44

and

45.2

46.0

0.8

2.24

BR-20-177*

24.8

25.4

0.6

2.59

and

63.5

66.2

2.7

1.12

VG

including

63.5

64.0

0.5

3.35

VG

and

118.8

121.5

2.7

0.58

and

159.5

161.5

2.0

1.65

and

186.0

190.5

4.5

3.99

VG

including

188.5

189.0

0.5

26.80

VG

BR-20-178*

34.0

35.0

1.0

8.61

and

60.7

66.2

5.5

0.76

including

64.2

64.7

0.5

3.47

and

81.2

83.7

2.5

1.28

BR-20-179*

7.0

9.0

2.0

3.38

including

8.0

8.5

0.5

10.10

and

23.8

26.8

3.0

0.82

and

29.5

31.5

2.0

3.13

VG

including

30.5

31.0

0.5

8.21

BR-20-180*

18.0

19.5

1.5

0.90

BR-20-181*

129.0

131.9

2.9

0.99

BR-20-182*

33.5

34.0

0.5

2.95

and

69.6

71.1

1.5

1.91

and

76.0

79.5

3.5

3.72

VG

including

76.5

77.0

0.5

12.70

and

77.0

77.5

0.5

8.13

VG

and

91.5

92.0

0.5

3.90

BR-20-183*

13.0

14.0

1.0

3.50

BR-20-143*

128.1

128.9

0.8

1.32

*Fire Assay Only

This news release has been reviewed and approved by Paul McNeill, P. Geo., VP Exploration with Anaconda Mining Inc., a "Qualified Person", under National Instrument 43-101 Standard for Disclosure for Mineral Projects.

All samples and the resultant composites referred to in this release are collected using QA/QC protocols including the regular insertion of standards and blanks within the sample batch for analysis and check assays of select samples. All samples quoted in this release were analyzed at Eastern Analytical Ltd. in Springdale, NL, for Au by fire assay (30 g) with an AA finish.

For drill holes BR-20-143 to BR-20-150, samples analyzing greater than 0.5 g/t Au via 30 g fire assay were re-analyzed at Eastern Analytical Ltd. via total pulp metallics. For the total pulp metallics analysis, the entire sample is crushed to -10mesh and pulverized to 95% -150 – mesh. The total sample is then weighed and screened to 150mesh. The +150 – mesh fraction is fire assayed for Au, and a 30 g subsample of the -150 – mesh fraction analyzed via fire assay. A weighted average gold grade is calculated for the final reportable gold grade. Drill holes BR-20-151 to BR-20-183 reported as fire assay only. Total pulp metallics assays for these drillholes will be updated in a future news release.

Reported mineralized intervals are measured from core lengths. Intervals are estimated to be approximately 70-100% of true widths.

A version of this press release will be available in French on Anaconda's website (www.anacondamining.com) in two to three business days.

ABOUT ANACONDA

Anaconda is a TSX and OTCQX-listed gold mining, development, and exploration company, focused in Atlantic Canada. The company operates mining and milling operations in the prolific Baie Verte Mining District of Newfoundland which includes the fully-permitted Pine Cove Mill, tailings facility and deep-water port, as well as ~11,000 hectares of highly prospective mineral lands including those adjacent to the past producing, high-grade Nugget Pond Mine at its Tilt Cove Gold Project. Anaconda is also developing the Goldboro Gold Project in Nova Scotia, a high-grade resource and the subject of an on-going feasibility study.

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking information" within the meaning of applicable Canadian and United States securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is based on the opinions and estimates of management at the date the information is made, and is based on a number of assumptions and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Anaconda to be materially different from those expressed or implied by such forward-looking information, including risks associated with the exploration, development and mining such as economic factors as they effect exploration, future commodity prices, changes in foreign exchange and interest rates, actual results of current production, development and exploration activities, government regulation, political or economic developments, environmental risks, permitting timelines, capital expenditures, operating or technical difficulties in connection with development activities, employee relations, the speculative nature of gold exploration and development, including the risks of diminishing quantities of grades of resources, contests over title to properties, and changes in project parameters as plans continue to be refined as well as those risk factors discussed in Anaconda's annual information form for the year ended December 31, 2019, available on www.sedar.com. Although Anaconda has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. Anaconda does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

FOR ADDITIONAL INFORMATION CONTACT:

Anaconda Mining Inc.
Kevin Bullock
President and CEO
(647) 388-1842
kbullock@anacondamining.com

Reseau ProMarket Inc.
Dany Cenac Robert
Investor Relations
(514) 722-2276 x456
Dany.Cenac-Robert@ReseauProMarket.com

Anaconda Mining Inc.
Lynn Hammond
VP, Corporate Affairs
(709) 330-1260
lhammond@anacondamining.com

Exhibit A: A map showing the location of drill holes and selected composited highlights referred to in this news release.

SOURCE: Anaconda Mining Inc.

ReleaseID: 617486

Market players are focusing on extending their market worldwide together with bringing an expanded product portfolio to attain an edge over the competitors.

DUBAI, UAE / ACCESSWIRE / November 19, 2020 / Future Market Insights: The tape dispenser market will grow at a CAGR of 3.8% over the forecast period, 2020-2030. The market growth can be primarily attributed to logistics and e-commerce industries. Growing online sales volumes of non-essential and essential products has amplified the requirement for effective packaging solutions, producing prospects for tap dispenser manufacturers.

"Escalated requirement for precision-based packaging solutions is boosting vendors to integrate technological developments such as AI to provide quality solutions to key end-users." concludes the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-2822

Tape Dispenser Market – Key Highlights

North America to remain the leading region poised to record a CAGR of 4% by 2030 end.
Table top dispensers is estimated to generate maximum revenue share by the end of 2030.
Automatic Tape Dispensers will record a CAGR of 4.3% during the forecast period.
Commercial & office usage to gain traction among other end use segments by 2030 end.

Tape Dispenser Market – Drivers

Escalating online food delivery market are catalyzing the need for advanced packaging solutions, thereby boosting the demand for tape dispensers.
Growing sales through e-commerce platforms support demand for advanced packaging solutions, ultimately offering prospects to tape dispenser manufacturers.
Technological innovations such as automated tape dispensers are estimated to offer new prospects to the tape dispenser market players

Tape Dispenser Market – Restraints

Several structural issues such as invisible starting point of the tape, proves to be a limitation to future growth.
Emitting undesired noises upon usage and not being sound-friendly restraints their application.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-2822

COVID-19 Impact on the Market

The tape dispenser market have been adversely impacted by the COVID-19 outbreak. The market is poised to record a downturn of -0.2% in 2020. However as per FMI's recent report, the market is anticipated to regain pace once the restriction imposed by the lockdowns are lifted. Need for e-commerce and logistics rest highly on constant supplies of essential products. Therefore, the requirement for remarkable packaging solutions increased demand for tape dispensers, and will keep it afloat.

Competitive Landscape

Key companies players identified in the tape dispenser market are Tesa SE, 3M Company, Fellow Brands, Intertape Polymer Group Inc., Koziol USA, Shurtape Technologies LLC, Prisma Pressure Sensitive Products Ltd., START International, Aroindia Electromech Pvt. Ltd. and Spec-Tech (Xiamen) Co. Ltd. Companies are engaged in expanding their outreach in the back of acquisitions, collaborations and product launches.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/2822

About the Study

The study offers readers a comprehensive assessment of the tape dispenser market. Global, regional and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights according to product type (hand held, table top, definite length dispensers and stretchable tape dispensers), by technology (automatic and manual), by end use (office & commercial and industrial) across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Table Of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Market Analysis

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage

2.2. Market Definition

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation Trends

4. Key Success Factors

4.1. Product Adoption Analysis

4.2. Product USPs / Features

5. Global Tape Dispenser Market Demand Analysis 2015-2019 and Forecast, 2020-2030

5.1. Historical Market Volume (‘000 Units) Analysis, 2015-2019

5.2. Current and Future Market Volume (‘000 Units) Projections, 2020-2030

5.3. Y-o-Y Growth Trend Analysis

6. Global Tape Dispenser Market – Pricing Analysis

6.1. Regional Pricing Analysis

6.2. Pricing Break-up

6.3. Global Average Pricing Analysis Benchmark

Download Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-2822

Explore FMI's Coverage of the Packaging Industry

Water Activated Tape Dispensers Market: Get insights on the water activated tape dispensers market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2017 – 2027.

Tear Tape Dispenser Market: FMI's exhaustive study on the global tear tape dispenser market covers the latest trends, innovations, key players, and popular strategies for the period 2020 – 2030.

Holographic Tear Tape Market: Obtain detailed analysis on the holographic tear tape market through FMI's report covering competitive analysis, key regions, and segmental analysis for 2019 – 2029.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/tape-dispenser-market

Press Release Source: https://www.futuremarketinsights.com/press-release/tape-dispenser-market

SOURCE: Future Market Insights

ReleaseID: 617557

VANCOUVER, BC / ACCESSWIRE / November 19, 2020 / Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is pleased to announce that as part of Sativa Wellness' commitment to safety and wellness in our communities, we are launching a private COVID-19 testing clinic inside our Goodbody Wellness store in Bath on 19th November.

The clinic will be providing PCR testing for travel and work, antigen testing (results in 15 minutes) as well as antibody testing for those who want to find out if they have had COVID 19 and to see if they have developed antibodies.

Customers book an appointment online, and will attend in-store to self-administer the test guided by a trained medical professional. The Company is already seeing strong demand in pre-bookings for this service.

Sativa Wellness provides numerous products to help customers during these challenging times, including our popular Goodbody Wellness CBD with vitamin D, and a complete range of hand sanitiser products designed for use in restaurants, businesses and for personal use, available in-store or online at "https://www.goodbodystore.com".

The UK Government is evaluating a ‘Test to Release' scheme which is expected to reduce the quarantine period after travelling abroad, by taking a test five or seven days after returning to the UK. However, negative tests are already a requirement when travelling to a number of countries from the UK. Appointments should be made in line with the Government guidelines on when your test is required for travel.

The private clinic is designed for people who aren't presenting symptoms but who need a negative test for travel, work or peace of mind when visiting vulnerable relatives. Anyone with symptoms should instead book an NHS test and follow the Government isolation procedures.

The PCR lab test is a swab sent for analysis at an accredited laboratory to test for the presence of COVID-19. A certificate delivered direct via email and SMS is provided to permit travelling and pass immigration. The test is 98% sensitive if the virus is found on the swab and has a 48-72-hour turnaround. The test cost £155.

A rapid antigen test is also available, which checks whether you are carrying the COVID-19 virus and could be infectious to others. Sensitivity is 92.5% and Specificity is 99.8%. Results are available in 15 minutes and the test costs £75.

Finally, an IgG and IgM rapid antibody test costing £55 is available which tests to see if you have already had COVID-19 and have developed antibodies. The test has an accuracy of 98.3% and results are available in just 15 minutes.

According to George Thomas, Managing Director of Goodbody Botanicals, "Our expertise in good health and wellbeing made it an obvious transition to be able to offer COVID testing in our store. The same attention to detail and care has been taken to ensure we can offer the best testing in a safe, calm environment. We hope this service will give people the peace of mind, and proof, required to return to travel, work and visiting friends and family when this is possible".

For more information or to book an appointment visit https://www.goodbodyclinic.com

The Directors of the Company accept responsibility for the contents of this announcement.

Further information regarding the Company can be found at www.sedar.com.

On behalf of the Board of Directors,

Henry Lees-Buckley
Chief Executive Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com

Joseph Colliver
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com

Jason Dussault
Investor Relations and Communications
Sativa Wellness Group Inc.
jason@sativawellnessgroup.com
www.sativawellnessgroup.com

Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Stillcanna's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". The forward-looking information and forward-looking statements contained herein include, but are not limited to information concerning the COVID-19 testing clinic, the accuracy of the results of the COVID-19 tests, and the availability of COVID-19 tests.

Although Sativa Wellness believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that any sales, profits or revenues will be derived from the agreement with the Health Store. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

SOURCE: Sativa Wellness Group Inc.

ReleaseID: 617447

COLLEGE STATION, TX / ACCESSWIRE / November 19, 2020 / Strategic Vaccines, LLC today announced that Lockheed Martin will conduct a computational study of the Strategic Vaccines' proprietary manufacturing systems designed to address emerging viral threats, beginning with COVID-19.

These proprietary Test and Go Rapid Deployment (TANGO-RDP) manufacturing systems will be housed at the Texas A&M Center for Innovation in Advanced Development and Manufacturing (Texas A&M CIADM) at College Station.

"Strategic Vaccines is manufacturing FLOVID-20, an inhaled treatment for COVID-19 designed to keep patients out of the hospital," said Reid Rubsamen, M.D., CEO, Strategic Vaccines, LLC. "The TANGO-RDP manufacturing systems we'll establish at the Texas A&M CIADM site will enable us to quickly address emerging viral threats. Lockheed Martin has a unique skill set matching our requirements and is helping us with that process."

The FLOVID-20 therapeutic is stable at room temperature and designed for delivery by inhalation to patients with a positive COVID-19 test. Strategic Vaccines, LLC is manufacturing FLOVID-20 at it's partner company Oakwood Laboratories in Solon, Ohio, and expects to begin clinical trials next year.

"Lockheed Martin's work with Strategic Vaccines at Texas A&M is a great opportunity to apply our technical resources and experience to help defeat the COVID-19 threat," said Michele Evans, Executive Vice President of Lockheed Martin Aeronautics. "This exemplifies one of our core values – ‘Do What's Right' – by using our unique aerospace expertise to serve a global need."

"The Texas A&M System is tirelessly working to respond to this deadly pandemic," said John Sharp,Chancellor of The Texas A&M University System. "We welcome Strategic Vaccines new teammate Lockheed Martin into our Texas A&M CIADM ecosystem."

About Strategic Vaccines

Strategic Vaccines, LLC is a Public Private Partnership ("PPP") including San Francisco Bay Area Biotech Flow Pharma, Inc. defense contractor M7TecGroup, Texas A&M University and Solon, Ohio based Oakwood Laboratories, LLC.

About Lockheed Martin

Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 110,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services.

About the Texas A&M Center for Innovation in Advanced Development and Manufacturing

The Texas A&M Center for Innovation in Advanced Development and Manufacturing (Texas A&M CIADM) is founded on an initial $285.6 million public-private partnership with the U.S. Department of Health and Human Services (DHHS) Biomedical Advanced Research and Development Authority (BARDA). The public/private partnership includes an initial investment of $176.6 million from the U.S. government with the remainder cost-shared by commercial and academic partners as well as the State of Texas Emerging Technology Fund. The Center for Innovation was awarded to the Texas A&M University System in June 2012 and is part of a national strategy recommended in the August 2010 Public Health Emergency Medical Countermeasures Enterprise Review.

As one of three centers established as public-private partnerships with the U.S. Department of Health and Human Services to develop and manufacture countermeasures, the Texas A&M Center for Innovation will respond to the need for rapid and flexible manufacturing to bolster the nation's ability to respond to any attack or threat, including novel, previously unrecognized, naturally occurring emerging infectious diseases, as well as various chemical, biological, radiological and nuclear threats.

It is designed to facilitate rapid research and development (R&D), promote novel product development through both public and private partnerships, ensure domestic manufacturing surge capacity, assist in FDA approval of products, as well as mentor the next generation of public health professionals through workforce training and outreach. The center will not only enhance the nation's ability to produce life-saving countermeasures quickly and nimbly, it will also transition processes and technologies that will broadly impact both national and global public health.

The Center is part of the Public Health Preparedness and Response initiative that has been established at the Texas A&M Health Science Center (TAMHSC).

Forward Looking Statements

This press release may contain forward-looking statements, including information about management's view of Flow Pharma, Inc. ("the Company"), future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this presentation other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included in this presentation are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Flow Pharma, Inc.

Media Contact:

ir@strategicvaccines.com

Strategic Vaccines, LLC
1041 Rellis Parkway, Suite 2312
College Station, Texas 77807

SOURCE: Strategic Vaccines, LLC

ReleaseID: 617505

DESTIN, FL / ACCESSWIRE / November 19, 2020 / Over 237,000 combat sports fans around the world downloaded the GoTV HD app after the official Xtreme Fighting Championships (OTC PINK:DKMR) channel was promoted on the XFC 43 broadcast on NBC Sports Network and FITE TV.

Launched earlier this month, the XFC's official home on GoTV HD is Channel 101. On the channel, MMA fans around the world have access to hundreds of hours of exclusive XFC content, including original content, behind-the-scenes footage, and all the best fights from the XFC vault.

XFC President Myron Molotky is pleased by the news, and says the dramatic uptick in downloads speaks to the reach and enthusiasm of XFC's global fan base.

"Mixed martial arts fans, especially fans of the XFC, are constantly craving to be closer to the action, and that's exactly where GoTV HD puts them. We're very excited to see so many combat sports fans get on board, because there's a whole world of XFC Hexagon action available, at your fingertips."

About XFC

Xtreme Fighting Championships, Inc. (formerly Duke Mountain Resources, Inc.) is the first publicly traded premier international mixed martial arts ("MMA") organization with offices throughout the United States and South America, trading under the ticker symbol DKMR. Xtreme Fighting Championships ("XFC") is now partnered with NBC Sports in the United States, and has previously been carried on some of the largest open television broadcasters in Latin America – Rede TV! as well as HBO, ESPN, Esportes Interativo, Terra TV (the largest internet portal in the world), and UOL – the largest internet portal in Latin America, and premium cable & satellite television network. The XFC has had over 185 exclusively signed fighters, representing over 35+ countries worldwide with even more growth expected. Boasting the signing of The Next Generation of Male & Female Superstars, the XFC is known for entertaining fans with the most action packed MMA events both on television and in stadium venues. The Next Generation of MMA.

About GoTV HD

GoTV HD is a new breed of OTT Live Broadcast Platform Entertainment fully controlled and owned by Global Oculus Media LLC. The OTT service is established to provide Live TV with rewind capabilities to US and worldwide markets accessible on web, mobile (iOS and Android) and Smart TV. This service caters to the underserved audiences and cord cutters with a freemium model for basic channels, subscription offers in skinny bundles, prepaid service that can be distributed in 11,000 brick-and-mortar locations. The network provides unparalleled speeds through its exclusive global telecom carriers with domestic and international network capabilities. The network has transport and PPV capabilities with unique positioning in the cable and OTT market distribution around the world. GO LIVE…GO STREAM…GO ANYWHERE.

Press Contact:

Jen Wenk, APR
jenwenkpr@gmail.com / 208.421.2919

CONTACT: Xtreme Fighting Championships, Inc.

ReleaseID: 617451

Industry Veterans Bring Deep Expertise and Experience to Tarus Board

NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Tarus Therapeutics Inc., an innovative biotechnology company developing adenosine receptor antagonists for cancer immunotherapy and select non-oncology indications, today announced the appointments of Mark Cohen as Chairman of the Board, and Robert Glassman, MD PhD, as a new Board Director (effective January 1, 2021).

Dr. Glassman has been a senior investment banker for 17 years, at Merrill Lynch for the majority of his career and as Vice Chairman at Credit Suisse since 2015. On transitioning from banking to OrbiMed Advisors, one of the world's largest dedicated healthcare investment firms, Dr. Glassman will be their only venture partner in public equity; he had been a private equity partner at OrbiMed 2009-2010. Earlier in his career, Dr. Glassman was with Merrill Lynch Global Private Equity where he oversaw a very successful healthcare portfolio and at McKinsey & Company for four years, where he consulted for a wide range of healthcare clients in the U.S. and Europe. Dr. Glassman is a board certified hematologist-oncologist who remains on the faculty as a Clinical Assistant Professor of Medicine at Weill Cornell. He has co-authored numerous articles in peer-reviewed journals and spoken widely in industry and academic forums on oncology clinical development, reimbursement, and data interpretation. Dr. Glassman has an AB from Harvard College and an MD from Harvard Medical School. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, and his fellowship in hematology and oncology at Weill Cornell. He also spent several years as a basic science investigator at Rockefeller University in the laboratory of Hidesaburo Hanafusa, where he received Howard Hughes Medical Institute and American Cancer Society awards.

Mr. Cohen is a founder of Pearl Cohen Zedek Latzer Baratz LLP, Senior Partner, Chair of the Life Sciences Practice Group, and a member of the firm's Executive Committee. Mark was a Board Director of Masthercell Global, Inc., a subsidiary of Orgenesis, Inc. (NASDAQ: ORGS), prior to its acquisition in February 2020 by Catalant, Inc. He was also Vice-Chairman of the Board and Chairman of Governance at Akari Therapeutics, Plc.

"I am excited to be joining the Board of Tarus as the company prepares to move from pre-clinical to clinical development, and honored to take on the role of Chairman," said Mr. Cohen. "I believe there is a significant opportunity for each of our programs in multiple cancer settings, as well as non-oncology indications. I look forward to working with the company to create value for patients and all stakeholders."

"Tarus is diligently advancing its oncology portfolio with the programs slated to enter clinic in early 2021. I look forward to supporting the team through this important inflection in the Company's development," added Dr. Glassman.

"We are delighted to welcome Mark and Robert to our Board of Directors at this exciting and significant phase for Tarus Therapeutics as we prepare to initiate multiple clinical studies," stated Dr. Sushant Kumar, Board Member and Chief Executive Officer of Tarus Therapeutics, Inc. "The addition of new directors complements our skills and experiences and we look forward to their guidance in bringing innovative and impactful immunotherapies to cancer patients."

About Tarus Therapeutics Inc.

Tarus is developing small molecule inhibitors of A2AR, A2BR, and Dual A2AR/A2BR inhibitors for cancer immunotherapy and select non-oncology indications. The Company has the most comprehensive portfolio of adenosine receptor antagonists in development, with both first-in-class and best-in-class programs. More information can be found at www.tarustx.com.

Contact:

Tarus Therapeutics, Inc.
Sushant Kumar, PhD
President & CEO
info@tarustx.com

SOURCE: Tarus Therapeutics, Inc. via EQS Newswire

ReleaseID: 617537